Discovery, design, and synthesis of indole-based EZH2 inhibitors
Victor S Gehling1, Rishi G Vaswani1, Christopher G Nasveschuk1
1Constellation Pharmaceuticals, Inc., 215 First Street, Cambridge, MA 02142, USA.
Abstract:
The discovery and optimization of a series of small molecule EZH2 inhibitors is described. Starting from dimethylpyridone HTS hit (2), a series of indole-based EZH2 inhibitors were identified. Biochemical potency and microsomal stability were optimized during these studies and afforded compound 22. This compound demonstrates nanomolar levels of biochemical potency (IC50=0.002 μM), cellular potency (EC50=0.080 μM), and afforded tumor regression when dosed (200 mpk SC BID) in an EZH2 dependent tumor xenograft model.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Diazonium Group Substitution: –OH and –H
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
E2 Reaction: Stereochemistry and Regiochemistry
When a substrate with two different β hydrogens undergoes an E2 elimination, the presence of a strong base can yield two regioisomeric alkenes. The more-substituted alkene is the major...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3


